GB607720A - Manufacture of biguanide derivatives - Google Patents

Manufacture of biguanide derivatives

Info

Publication number
GB607720A
GB607720A GB35238/45A GB3523845A GB607720A GB 607720 A GB607720 A GB 607720A GB 35238/45 A GB35238/45 A GB 35238/45A GB 3523845 A GB3523845 A GB 3523845A GB 607720 A GB607720 A GB 607720A
Authority
GB
United Kingdom
Prior art keywords
chloro
methyl
iodo
bromo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35238/45A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB35238/45A priority Critical patent/GB607720A/en
Priority to FR954888D priority patent/FR954888A/fr
Priority to ES176286A priority patent/ES176286A1/en
Priority to FR58093D priority patent/FR58093E/en
Publication of GB607720A publication Critical patent/GB607720A/en
Priority to CY7549A priority patent/CY75A/en
Priority to MY12/54A priority patent/MY5400012A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Biguanide derivatives of the general formula RR1N-C(: NH) - NH-C(: NH)-NR11R111, wherein R1 and R111 may each represent hydrogen or a hydrocarbon radical and R and R11 may each represent a hydrocarbon radical, provided that of the groups represented by R, R1, R11 and R111 (any or all of which may bear one or more non-acidic substituents) at least one but not more than two must be aryl, are manufactured by interaction of a guanidine derivative RR1N-C(: NH)-NH2 with a cyanamide derivative R11R111NCN. The reaction may be effected by heating the reactants together, optionally in the presence of a solvent or diluent, the guanidine derivative being used in the form of the free base or as a salt, whilst if the cyanamide is monosubstituted it may be used in the form of a salt with a base (in which case the guanidine derivative is also used in the form of a salt). The products are useful as chemotherapeutic agents or intermediates therefor, antimalarial activity being particularly marked in those in which one of the two pairs of substituents (R and R1 or R11 and R111) contains more than one and fewer than eight carbon atoms, whilst of the other pair one is hydrogen and the other a phenyl radical substituted by at least one halogen atom in m- or p-position to the nitrogen atom, e.g. substituted by chlorine, bromine or iodine in the m- or p-position and bearing another substituent, such as an alkyl or alkoxy group, in the p- or m-position respectively, or substituted by halogen in both one m-position and the p-position, or in both m-positions, or in both m-positions and the p-position. Salts of the products with organic and inorganic acids, e.g. acetic, lactic, methanesulphonic, methylenedisalicylic, methylene - bis - 2 : 3 - hydroxynaphthoic or hydrochloric acid, are obtainable by dissolving the biguanides in aqueous solutions of the acids and evaporating off the water, or preferably by mixing the components in an organic solvent, e.g. acetone or an alcohol in which the salts are sparingly soluble. In examples: (1) p - chlorophenylguanidine is heated with dimethylcyanamide to produce N a -p-chlorophenyl-No -dimethylbiguanide; (2) diethylcyanamide and methylisopropylcyanamide similarly yield the No -diethyl and No -methyl-No -isopropyl derivatives respectively; (3) p-chlorophenylguanidine and phenylmethylcyanamide are refluxed in n-butanol to give Na - p - chlorophenyl - No - phenyl - No - methylbiguanide; (4) to (26) from the appropriate intermediates there are similarly prepared Na - p - iodo-, -m - chloro-, -3 : 4 - dichloro-, -3-chloro-4-bromo- and -iodo-, -3 : 5-dichloro-, -3 : 4 : 5 - trichloro-, -3 - chloro - 4 - methyl-, -4-chloro-3-methyl- and -m-bromo-phenyl-N-isopropylbiguanide, Na - p - iodophenyl - No - methyl - No -isopropylbiguanide, Na -p-chloro-phenyl-No -isopropylbiguanide, Na -p-methoxy-phenyl - No - dimethylbiguanide, Na - p - chloro-and -p-methoxy - phenyl - No - cyclohexylbiguanide, Na -p-chlorophenyl-No -p-tolylbiguanide, Na -p-tolyl-No -diethyl- and -No -cyclohexylbiguanide, Na -p-bromophenyl-No -n-propylbiguanide, Na -diphenyl-No -isopropylbiguanide and Na - p - bromophenyl - No - diethyl-, -No -ethyl-No -methyl-No -isopropyl-biguanide; (29) p-chlorophenylguanidine hydrochloride and dimethylcyanamide are refluxed in n-butanol, yielding the product of (1); (28) phenylguanidine carbonate and p-chlorophenylcyanamide similarly yield Na -p-chlorophenyl-No -phenylbiguanide; (29) a mixture of p-chlorophenylguanidine, its hydrochloride, diethylcyanamide and toluene is refluxed to produce Na -p-chlorophenyl-No -diethylbiguanide; (30) the reaction of (29) is carried out in n-butanol and using a smaller proportion of the hydrochloride, and the product is purified by way of its copper complex compound; (31) isopropylcyanamide similarly yields Na -p-chlorophenyl-No -isopropylbiguanide, which is converted into its acetate; (32) isopropylguanidine sulphate is shaken with a solution of sodium in n-butanol, and the resulting solution is refluxed with p-chlorophenylcyanamide to give the product of (31); from the appropriate alkylguanidine salts there are similarly obtained: (33) the product of (1), and (34) Na -p-chlorophenyl-No -methylbiguanide; (35) dimethylguanidine sulphate is refluxed with a solution of sodium in n-butanol, the mixture is cooled and filtered and the solution refluxed with phenylmethylcyanamide to produce Na -phenyl-Na -methyl-No -dimethylbiguanide; (36) to (41) from the appropriate arylcyanamides and alkylguanidine salts there are similarly prepared Na -diphenyl-No -dimethylbiguanide, Na -phenyl-No -methyl-and -No - isopropyl - biguanide, Na - diphenyl - No - isopropylbiguanide, and Na - p - bromophenyl-No -methyl- and -No -cyclohexylbiguanide; (42) N : N-phenylmethylguanidine hydrochloride and phenylmethylcyanamide are similarly reacted to form Na -No -diphenyl-Na -No -dimethylbiguanide; (43) to (47) from the appropriate arylguanidine salts and substituted cyanamides there are similarly prepared Na -p-bromophenyl-No -dimethyl-, -No -phenyl-No -methyl-, -No -isopropyl-, -No -isobutyl- and -No - methyl - No - n - butyl - biguanide; (48) p - bromophenylguanidine hydrate is mixed with pentanol, part of the pentanol is distilled off and the resulting dry solution is refluxed with diethylcyanamide to produce N-a -bromophenyl - No - diethylbiguanide; (49) n -butyl - cyanamide similarly yields Na -p-bromophenyl-No -n-butylbiguanide; (50) sodium p-chloro-phenylcyanamide (obtained by treating p-chlorophenylcyanamide in ether with excess of a solution of sodium methoxide in methanol) is refluxed with cyclohexylguanidine in n-butanol to give Na - p - chlorophenyl - No - cyclohexylbiguanide. Additional starting materials specified are m-iodo-, 3-bromo-4-iodo-, 3 : 4-dibromo-, 3-iodo-4-chloro-, p-nitro-, 3-iodo-4-bromo-, 3 : 4-diiodo-, 3 : 5-dichloro-4-bromo-and -iodo- and 4-chloro-3-bromo-phenylguanidine, ethylguanidine, N : N-diethylguanidine, n-propylguanidine, N : N-methyl-n-propylguanidine, N : N - methylisopropylguanidine, N : N - methyl-n - butylguanidine and n - butylguanidine; methyl - n - propylcyanamide, di - n - butylcyanamide, o- and m-tolylcyanamide, p-anioylcyanamide, p-phenetylcyanamide, a - and b -naphthylcyanamide, 3 : 4- and 3 : 5-dichloro-, 3-iodo-4-bromo-, 3 : 4-diiodo-, 3-chloro-4-methyl-, 3 : 5-dichloro-4-bromo- and -iodo-, p- and m-iodo-, 3-chloro-4-bromo- and -iodo-, 3-bromo-4-chloro-and -iodo-, 3 : 4-dibromo-, 3-iodo-4-chloro-, p-hydroxy-, m-chloro-, 3 : 4 : 5-trichloro-, p-nitro-, 4-chloro-3-methyl- and m-bromo-phenyl-cyanamide. Guanidine derivatives of the kind employed as starting materials are obtainable in the form of their hydrochlorides by condensing the appropriate amine hydrochloride with cyanamide, or (when free from aryl groups) in the form of their sulphates by reaction of the appropriate amine with S-methylisothiourea sulphate. Cyanamides of the general formula given above but containing only alkyl groups are obtainable by the action of bromine on a mixture of the appropriate amine and potassium cyanide, whilst those containing aryl groups may be made by the action of an alkaline lead solution on the corresponding thiourea. Isopropylcyanamide is obtainable by adding cyanogen bromide to a solution of excess of isopropylamine in petroleum ether between -5 DEG and 0 DEG C., the solution obtained after filtering off the isopropylamine hydrobromide formed being suitable for immediate use in example (31).
GB35238/45A 1945-12-31 1945-12-31 Manufacture of biguanide derivatives Expired GB607720A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB35238/45A GB607720A (en) 1945-12-31 1945-12-31 Manufacture of biguanide derivatives
FR954888D FR954888A (en) 1945-12-31 1946-12-31
ES176286A ES176286A1 (en) 1945-12-31 1946-12-31 A PROCEDURE FOR THE OBTAINING OF BIGUANIDA DERIVATIVES
FR58093D FR58093E (en) 1945-12-31 1948-03-15 Manufacturing process for biguanide derivatives
CY7549A CY75A (en) 1945-12-31 1949-02-04 Manufacture of biguanide derivatives
MY12/54A MY5400012A (en) 1945-12-31 1954-12-30 Manufacture of biguanide derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB35238/45A GB607720A (en) 1945-12-31 1945-12-31 Manufacture of biguanide derivatives
FR58093T 1948-03-15

Publications (1)

Publication Number Publication Date
GB607720A true GB607720A (en) 1948-09-03

Family

ID=61024212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35238/45A Expired GB607720A (en) 1945-12-31 1945-12-31 Manufacture of biguanide derivatives

Country Status (4)

Country Link
CY (1) CY75A (en)
FR (2) FR954888A (en)
GB (1) GB607720A (en)
MY (1) MY5400012A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2529992A (en) * 1948-02-20 1950-11-14 Usines Chimiques Rhone Poulene Production of n'-p-chlorophenyl-n-isopropyl biguanide
US2556315A (en) * 1948-02-20 1951-06-12 Rhone Poulenc Sa Production of a salt of p-chlorophenyl cyanamide and isopropylguanidine
US2606923A (en) * 1950-05-13 1952-08-12 Rohm & Haas Tertiary alkylcyanamides
WO2010132982A1 (en) * 2009-05-18 2010-11-25 Ottawa Hospital Research Institute Treatment of muscle disease characterized by insulin resistance
EP2522653A2 (en) * 2010-01-06 2012-11-14 HanAll Biopharma Co., Ltd. Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US10626085B2 (en) 2014-11-20 2020-04-21 Immunomet Therapeutics Inc. Biguanide compound and use thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2529992A (en) * 1948-02-20 1950-11-14 Usines Chimiques Rhone Poulene Production of n'-p-chlorophenyl-n-isopropyl biguanide
US2556315A (en) * 1948-02-20 1951-06-12 Rhone Poulenc Sa Production of a salt of p-chlorophenyl cyanamide and isopropylguanidine
US2606923A (en) * 1950-05-13 1952-08-12 Rohm & Haas Tertiary alkylcyanamides
WO2010132982A1 (en) * 2009-05-18 2010-11-25 Ottawa Hospital Research Institute Treatment of muscle disease characterized by insulin resistance
US8993633B2 (en) 2009-05-18 2015-03-31 Fate Therapeutics, (Canada) Inc. Treatment of muscle disease characterized by insulin resistance
EP2522653A2 (en) * 2010-01-06 2012-11-14 HanAll Biopharma Co., Ltd. Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
EP2522653A4 (en) * 2010-01-06 2013-06-12 Hanall Biopharma Co Ltd Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US9416098B2 (en) 2010-01-06 2016-08-16 Immunomet Therapeutics Inc. Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US9993446B2 (en) 2010-01-06 2018-06-12 Immunomet Therapeutics Inc. Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US10376480B2 (en) 2010-01-06 2019-08-13 Immunomet Therapeutics Inc. Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US10626085B2 (en) 2014-11-20 2020-04-21 Immunomet Therapeutics Inc. Biguanide compound and use thereof
US11572341B2 (en) 2014-11-20 2023-02-07 Immunomet Therapeutics Inc. Biguanide compound and use thereof

Also Published As

Publication number Publication date
MY5400012A (en) 1954-12-31
FR58093E (en) 1953-09-21
FR954888A (en) 1950-01-06
CY75A (en) 1949-02-04

Similar Documents

Publication Publication Date Title
US3966726A (en) Process for the production of cyclic carboxylic acid imides
GB607720A (en) Manufacture of biguanide derivatives
US2302749A (en) Dithiocarbamates
US2810726A (en) Alpha-halo-alpha'-imino-substituted pyrrolines and piperideines and their acid saltsand method for their preparation
US2675375A (en) Arylazopyrimidine compounds and methods of making the same
US2124594A (en) Diazoamino compounds
US2657231A (en) Process for producing alkylene-bis-dithio-alkylene and -arylene-dicarboxylic acids
US3135793A (en) Hydroxyalkylenediminotetracetamides
GB599714A (en) Manufacture of biguanide derivatives
GB950521A (en) Pyrimidinyl-guanazoles
Tsuji Researches on Chemotherapeutic Drugs against Viruses. XVII.: Synthesis and Antiviral Properties of Urazoles and Related Compounds.
US2875204A (en) 2-amino-3-(p-chlorophenylimino)-3, 5-dihydro-5-(p-chlorophenyl)-phenazine and salts thereof
US2644003A (en) Quaternary ammonium compounds and their manufacture
US2561948A (en) Aminoalkylated diamino diphenyl sulfones
US2295884A (en) P-substituted-benzenesulphonyl biguanides and methods for their preparation
GB823001A (en) Acaricidal compositions
GB721171A (en) Derivatives of ª‰- and ª†- carbolines
US2775595A (en) Chzohz
US1677640A (en) Solid diazosalt
CA1056398A (en) Derivatives of 1-hydroxy-benzo-2,3,1-diazaborine and process for their preparation
US2524729A (en) 2-amino-5-benzyl-1, 3, 4-thiadiazole and acid salts thereof
US2498217A (en) Chlorinated isomelamines
GB677540A (en) Improvements in or relating to the manufacture of benziminazoles
US2666063A (en) Mercaptohydantoins
US2191860A (en) Biguanidino substituted diphenyleneoxides